January 14, 2019
Dechra reports expected increase in net revenue for last six months
Dechra continues to deliver above market revenue growth in our existing business and in our acquisitions, in line with the Board’s expectations, Ian Page, Chief Executive Officer, said in company’s half year trading period update, which highlights growth in European and North American pharmaceuticals net revenue, as well as the Laboratories Vancofarma do Brasil acquisition.
